Citigroup’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.2M | Buy |
24,800
+4,700
| +23% | +$2.55M | 0.01% | 1347 |
|
|
2025
Q4 | $11.6M | Sell |
20,100
-24,000
| -54% | -$13.6M | 0.01% | 1418 |
|
|
2025
Q3 | $21.4M | Sell |
44,100
-76,000
| -63% | -$35.4M | 0.01% | 1020 |
|
|
2025
Q2 | $48.7M | Buy |
120,100
+70,400
| +142% | +$29.4M | 0.02% | 602 |
|
|
2025
Q1 | $24.7M | Sell |
49,700
-43,100
| -46% | -$23.3M | 0.01% | 852 |
|
|
2024
Q4 | $48.3M | Buy |
92,800
+32,100
| +53% | +$17.6M | 0.03% | 530 |
|
|
2024
Q3 | $37.5M | Sell |
60,700
-5,200
| -8% | -$3.08M | 0.02% | 653 |
|
|
2024
Q2 | $36.4M | Sell |
65,900
-12,300
| -16% | -$7.05M | 0.02% | 630 |
|
|
2024
Q1 | $45.5M | Sell |
78,200
-22,800
| -23% | -$12.8M | 0.03% | 531 |
|
|
2023
Q4 | $53.6M | Buy |
101,000
+26,300
| +35% | +$12.7M | 0.04% | 433 |
|
|
2023
Q3 | $37.8M | Buy |
74,700
+7,800
| +12% | +$4.16M | 0.03% | 531 |
|
|
2023
Q2 | $34.9M | Buy |
66,900
+5,000
| +8% | +$2.7M | 0.02% | 584 |
|
|
2023
Q1 | $35.7M | Buy |
61,900
+11,300
| +22% | +$6.37M | 0.03% | 531 |
|
|
2022
Q4 | $27.9M | Buy |
50,600
+25,700
| +103% | +$13.6M | 0.02% | 641 |
|
|
2022
Q3 | $12.6M | Sell |
24,900
-5,700
| -19% | -$3.19M | 0.01% | 1028 |
|
|
2022
Q2 | $16.6M | Sell |
30,600
-11,300
| -27% | -$6.22M | 0.01% | 886 |
|
|
2022
Q1 | $24.7M | Sell |
41,900
-25,500
| -38% | -$14.6M | 0.02% | 833 |
|
|
2021
Q4 | $45M | Sell |
67,400
-9,400
| -12% | -$5.87M | 0.02% | 601 |
|
|
2021
Q3 | $43.9M | Sell |
76,800
-38,000
| -33% | -$20.9M | 0.03% | 590 |
|
|
2021
Q2 | $57.9M | Buy |
114,800
+53,300
| +87% | +$25.1M | 0.03% | 472 |
|
|
2021
Q1 | $28.1M | Sell |
61,500
-63,300
| -51% | -$30.2M | 0.02% | 765 |
|
|
2020
Q4 | $58.1M | Buy |
124,800
+200
| +0.2% | +$93.8K | 0.03% | 469 |
|
|
2020
Q3 | $55M | Buy |
124,600
+10,700
| +9% | +$4.42M | 0.04% | 411 |
|
|
2020
Q2 | $41.3M | Hold |
113,900
| – | – | 0.03% | 460 |
|
|
2020
Q1 | $32.3M | Buy |
113,900
+31,100
| +38% | +$9.81M | 0.03% | 522 |
|
|
2019
Q4 | $26.9M | Buy |
82,800
+40,100
| +94% | +$12.2M | 0.02% | 800 |
|
|
2019
Q3 | $12.4M | Buy |
42,700
+35,600
| +501% | +$10.2M | 0.01% | 1241 |
|
|
2019
Q2 | $2.08M | Sell |
7,100
-17,300
| -71% | -$4.76M | ﹤0.01% | 2796 |
|
|
2019
Q1 | $6.68M | Sell |
24,400
-11,400
| -32% | -$2.84M | 0.01% | 1561 |
|
|
2018
Q4 | $8.01M | Buy |
35,800
+8,400
| +31% | +$1.97M | 0.01% | 1426 |
|
|
2018
Q3 | $6.69M | Sell |
27,400
-1,300
| -5% | -$299K | 0.01% | 1581 |
|
|
2018
Q2 | $5.95M | Buy |
28,700
+3,300
| +13% | +$700K | 0.01% | 1675 |
|
|
2018
Q1 | $5.24M | Sell |
25,400
-19,900
| -44% | -$4.18M | ﹤0.01% | 1707 |
|
|
2017
Q4 | $8.6M | Buy |
45,300
+13,700
| +43% | +$2.62M | 0.01% | 1395 |
|
|
2017
Q3 | $5.98M | Buy |
31,600
+12,300
| +64% | +$2.23M | ﹤0.01% | 1591 |
|
|
2017
Q2 | $3.37M | Sell |
19,300
-14,200
| -42% | -$2.39M | ﹤0.01% | 2063 |
|
|
2017
Q1 | $5.15M | Sell |
33,500
-20,300
| -38% | -$3.1M | ﹤0.01% | 1646 |
|
|
2016
Q4 | $7.59M | Buy |
53,800
+28,200
| +110% | +$4.16M | 0.01% | 1426 |
|
|
2016
Q3 | $4.07M | Buy |
25,600
+7,500
| +41% | +$1.16M | ﹤0.01% | 1848 |
|
|
2016
Q2 | $2.67M | Sell |
18,100
-8,300
| -31% | -$1.23M | ﹤0.01% | 2117 |
|
|
2016
Q1 | $3.74M | Sell |
26,400
-41,300
| -61% | -$5.53M | ﹤0.01% | 1822 |
|
|
2015
Q4 | $9.6M | Buy |
67,700
+29,300
| +76% | +$3.91M | 0.01% | 1183 |
|
|
2015
Q3 | $4.7M | Sell |
38,400
-19,600
| -34% | -$2.55M | ﹤0.01% | 1714 |
|
|
2015
Q2 | $7.53M | Buy |
58,000
+15,000
| +35% | +$1.96M | 0.01% | 1415 |
|
|
2015
Q1 | $5.78M | Buy |
43,000
+17,700
| +70% | +$2.28M | 0.01% | 1617 |
|
|
2014
Q4 | $3.17M | Buy |
25,300
+10,600
| +72% | +$1.29M | ﹤0.01% | 2134 |
|
|
2014
Q3 | $1.79M | Buy |
14,700
+9,500
| +183% | +$1.16M | ﹤0.01% | 2625 |
|
|
2014
Q2 | $614K | Buy |
+5,200
| New | +$612K | ﹤0.01% | 3320 |
|
Other funds holding TMO
VCM
Citigroup's TMO Position: Q1 2026 in Review
Citigroup increased its Thermo Fisher Scientific (TMO) stake by 6.6% in Q1 2026, buying an estimated $19.2M and bringing the position to 572,177 shares worth $281M. The position accounts for 0.12% of the portfolio, ranked #162.
Citigroup first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $620M in Q2 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Citigroup held 572,177 shares of Thermo Fisher Scientific worth $281M as of Q1 2026.
- Citigroup bought 35,391 Thermo Fisher Scientific shares in Q1 2026, an estimated $19.2M.
- Thermo Fisher Scientific made up 0.12% of Citigroup's portfolio in Q1 2026, its #162 holding.
- Citigroup first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Thermo Fisher Scientific position peaked at $620M in Q2 2024.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.